New CMAC partnership with Shimadzu boosts automation and data-driven research
Shimadzu has joined CMAC as its latest Tier Two partner, marking a further step in strengthening collaboration to advance laboratory automation, data integration and next-generation workflows for pharmaceutical research and development.
The partnership will see Shimadzu work closely with CMAC staff and students to integrate and showcase its instrumentation, automation platforms and data solutions across CMAC’s research facilities. Early areas of the collaboration will focus on enabling instrument workflows in real laboratory environments, contributing to CMAC’s ongoing “lab of the future” initiatives.
By aligning Shimadzu’s technologies with CMAC’s expertise in digital chemistry and advanced manufacturing, the collaboration is expected to accelerate innovation and drive more connected, data-rich research environments.
Enabling real-world innovation
A key focus of the partnership is to demonstrate practical, real-world applications of advanced technologies. Through joint activity, the organisations aim to:
Showcase real use cases, highlighting CMAC’s capabilities in automation, online sampling and data-driven decision-making
Support data and systems integration, enabling Shimadzu’s platforms to export raw data and metadata into CMAC’s knowledge graphs and analytics systems
Create machine-readable research outputs, supporting reproducibility, searchability and advanced analytics
Enhance researcher capability, by familiarising CMAC scientists with Shimadzu technologies in an educational setting and surfacing new academic use cases
This integrated approach is designed to bridge the gap between instrumentation, data capture and digital insight, an increasingly critical requirement in modern pharmaceutical R&D.
Mutual benefits across research and development
The partnership is expected to deliver strong benefits for both organisations. CMAC will gain access to Shimadzu’s advanced instrumentation, technical expertise and commercial insight, which can be embedded directly into its research programmes and teaching activities.
For Shimadzu, the collaboration provides a valuable opportunity to engage with cutting-edge academic research. Access to CMAC’s real-world workflows will support product validation and development, while also enabling the co-promotion of successful technology integrations.
“As UK Head of Sales and Marketing at Shimadzu, I am delighted to support this collaboration with CMAC.
By combining Shimadzu’s expertise in analytical instrumentation, automation and data-led solutions with CMAC’s world-leading research environment, we have a valuable opportunity to help advance more connected, efficient and sustainable laboratory workflows, supporting the future of pharmaceutical manufacturing.”
Driving the ‘lab of the future’
This latest partnership reinforces CMAC’s role as a hub for innovation in digital and automated chemistry. By combining industry-leading technologies with academic expertise, the collaboration aims to accelerate progress towards fully integrated, intelligent laboratory environments.
As the pharmaceutical sector continues to evolve, partnerships such as this are set to play a crucial role in shaping more efficient, data-driven and reproducible research ecosystems.
ABOUT CMAC
CMAC is an internationally leading medicines manufacturing research centre led by the University of Strathclyde. Combining academic excellence with applied and pre-competitive research, CMAC partners with industry, academia and innovation stakeholders, including government and funding agencies, to transform medicines development, manufacture, and supply.
Our National Facility and vibrant portfolio of projects enable industry collaboration on cutting-edge research. Through advanced training and translation programmes, CMAC equips researchers and professionals with the skills to lead innovation in digital pharmaceutical manufacturing, supporting the sector’s evolution toward more resilient, sustainable and patient-focused solutions.
ABOUT Shimadzu
Shimadzu is a global manufacturer of analytical and measuring instruments, medical systems and industrial equipment, founded in Kyoto, Japan, in 1875. Guided by its corporate philosophy of “Contributing to Society through Science and Technology”, Shimadzu develops technologies used across research, quality control, healthcare, environmental analysis and advanced manufacturing.
With a long-standing focus on innovation, reliability and customer support, Shimadzu provides instrumentation and data-led solutions that help laboratories improve productivity, generate high-quality results and accelerate scientific progress.
Shimadzu also places strong emphasis on sustainability and responsible innovation, supporting customers with technologies that help improve efficiency, reduce resource use and enable more sustainable scientific workflows. Its continued investment in automation, data connectivity and advanced analytical solutions reflects a commitment to helping researchers work more efficiently while accelerating discovery and innovation.